Camrelizumab combined with transcatheter arterial chemoembolization and sorafenib or lenvatinib for unresectable hepatocellular carcinoma: A multicenter, retrospective study

Introduction and Objectives: We initiated this study to explore the efficacy of camrelizumab combined with transcatheter arterial chemoembolization (TACE) plus sorafenib or lenvatinib versus TACE plus sorafenib or Lenvatinib for unresectable hepatocellular carcinoma (HCC). Materials and Methods: Fro...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	Xiumei Jiang, Pan Wang, Ke Su, Han Li, Hao Chi, Fei Wang, Yu Liu, Ke Xu
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	Elsevier 2025-07-01
Seri Bilgileri:	Annals of Hepatology
Konular:	Camrelizumab Transcatheter arterial chemoembolization Hepatocellular carcinoma Sorafenib Lenvatinib
Online Erişim:	http://www.sciencedirect.com/science/article/pii/S1665268124003612
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!